National Health Act 1953

The price disclosure requirements for a supply of a brand of a pharmaceutical item are:

to provide information prescribed by the regulations in relation to the supply of the brand of the pharmaceutical item by the responsible person to a person or entity prescribed by the regulations; and

to provide that information in the manner and form prescribed by the regulations; and

to provide that information at the times prescribed by the regulations.

Without limiting subsection (1), the regulations may prescribe information relating to:

the price of the brand of the pharmaceutical item supplied, which may be by reference to the quantity or number of units of the pharmaceutical item supplied; and

the volume of the supply; and

the person to whom the supply was made; and

when the supply was made; and

the type and value of any benefit (whether monetary or otherwise) provided to persons by the responsible person in relation to the supply, whether or not the benefit also relates to another supply of a product (the related product) that is:

the brand of the pharmaceutical item; or

any other pharmaceutical item available in the brand or any other brand; or

any other product; and

if the benefit referred to in paragraph (e) also relates to a supply of the related product—information relating to the supply of the related product (including the price and volume of the supply); and

any other matter that is relevant in determining the weighted average disclosed price of the brand of the pharmaceutical item.